Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Dentomaxillofac Radiol ; 36(1): 2-6, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17329580

RESUMO

OBJECTIVE: The purpose of this investigation was to determine the reproducibility among observers and accuracy of the measurement of the tooth crown width of unerupted teeth using limited area cone beam X-ray CT. METHODS: 3DX multi-image micro-CT (3DX, Morita Co., Kyoto, Japan) images of impacted supernumerary teeth in the median maxillary region taken prior to extraction were used for the samples. The width of the tooth on the 3DX image was measured five times by five individual observers. Significant differences in values among the observers in the measurement were determined by one-way analysis of variance for examining reproducibility. The measurement results of the ten samples on 3DX images were compared with the laboratory measurements using a three-dimensional co-ordinate measuring apparatus, using the Wilcoxon signed-rank sum test. RESULTS: There was no significant difference among the observers in the measurement (P>0.05). The measurement results shown on 3DX images were significantly larger than those of the laboratory measurements (P<0.05). The mean difference was +0.088 mm. CONCLUSIONS: 3DX has high reproducibility for measuring the tooth crown width of unerupted teeth. While 3DX measurement values were larger than the laboratory measurements, the difference is clinically insignificant.


Assuntos
Tomografia Computadorizada por Raios X/métodos , Dente não Erupcionado/diagnóstico por imagem , Criança , Pré-Escolar , Feminino , Humanos , Processamento de Imagem Assistida por Computador , Imageamento Tridimensional/métodos , Masculino , Maxila/diagnóstico por imagem , Variações Dependentes do Observador , Odontometria , Reprodutibilidade dos Testes , Tomografia Computadorizada por Raios X/estatística & dados numéricos , Coroa do Dente/diagnóstico por imagem , Coroa do Dente/patologia , Dente Supranumerário/diagnóstico por imagem , Dente Supranumerário/patologia , Dente não Erupcionado/patologia
2.
Endocr J ; 48(2): 139-42, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11456259

RESUMO

A 45 year-old man had a typical episode of subacute thyroiditis with tender goiter, depressed radioiodine uptake (RAIU) and elevated erythrocyte sedimentation rate. The titer of TSH binding inhibitor immunoglobulin (TBII), which had been 8.6% at initial presentation, rose to 14.9% in 2 weeks. TBII consisted of high titers (94%) of TSH stimulation-blocking antibodies (TBAb) and negative thyroid stimulating antibodies (TSAb). About 2 months after the first visit, TBII titers had risen to 48.9% and were persistently elevated for 5 months with high TBAb activity. The patient developed hypothyroidism with a maximum serum TSH level of 54.5 microU/ml. TBII and TBAb titers then gradually decreased, and the patient spontaneously recovered from hypothyroidism. Eighteen months after the episode of subacute thyroiditis, he became hyperthyroid with elevated TSAb and negative TBAb values. Doppler ultrasonography showed increased blood flow in the thyroid, and RAIU at 24 h was 53%. He was treated with antithyroid drugs, and soon became euthyroid. This case indicates that subacute thyroiditis can induce thyroid autoimmunity, and that the character of TSH receptor antibodies (TSHRAb) in these patients can change thereby modifying their thyroid function.


Assuntos
Autoanticorpos/imunologia , Doenças Autoimunes/etiologia , Hipotireoidismo/imunologia , Receptores da Tireotropina/imunologia , Tireoidite/complicações , Antitireóideos/uso terapêutico , Autoanticorpos/sangue , Humanos , Hipertireoidismo/tratamento farmacológico , Hipertireoidismo/etiologia , Hipotireoidismo/etiologia , Imunoglobulinas Estimuladoras da Glândula Tireoide/sangue , Radioisótopos do Iodo , Masculino , Pessoa de Meia-Idade , Propiltiouracila/uso terapêutico , Receptores da Tireotropina/sangue , Glândula Tireoide/irrigação sanguínea , Glândula Tireoide/diagnóstico por imagem , Tireoidite/diagnóstico , Tireotropina/sangue , Tiroxina/sangue , Tri-Iodotironina/sangue , Ultrassonografia
3.
Eur J Pharmacol ; 421(2): 93-100, 2001 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-11399264

RESUMO

Differentiation-inducing factor (DIF) is a lipophilic hormone of Dicytostelium discoideum and has been shown to exert diverse effects in mammalian cells. We investigated the effect of DIF on cell viability in insulin-secreting INS-1 cells. DIF induced cell death in a dose-dependent manner. In DIF-treated cells, nuclear condensation and shrinkage of the cell body were observed. After 6 h of DIF treatment, cells became Tdt-mediated dUTP-biotin nick end-labeling-positive, and DNA ladder formation was detected, indicating that DIF induced apoptosis in these cells. DIF did not activate caspase-3, a key enzyme mediating apoptotic signals generated by various agents. Furthermore, DIF-induced cell death was not affected by Z-asp-2, 6-dichlorobenzoyloxymethylketone, a broad inhibitor of the caspases. As is the case in other types of cells, DIF increased cytoplasmic free calcium concentration in INS-1 cells. However, DIF-induced cell death was not affected by chelating intracellular free calcium by 1, 2-bis(2-aminoophenoxy)ethane-N, N, N, N-tetra acetic acid (BAPTA). These results indicate that DIF induces apoptosis in INS-1 cells by a mechanism independent of caspase-3. DIF-induced elevation of cytoplasmic calcium does not mediate the effect of DIF on cell death.


Assuntos
Apoptose/efeitos dos fármacos , Caspases/metabolismo , Hexanonas/farmacologia , Animais , Cálcio/metabolismo , Caspase 3 , Sobrevivência Celular/efeitos dos fármacos , Quelantes/farmacologia , Ácido Egtázico/análogos & derivados , Ácido Egtázico/farmacologia , Ionomicina/farmacologia , Fosfatidilinositol 3-Quinases/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/metabolismo , Proteínas Proto-Oncogênicas/efeitos dos fármacos , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Fatores de Tempo , Células Tumorais Cultivadas/citologia , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/metabolismo , Proteína X Associada a bcl-2
4.
J Int Med Res ; 29(2): 108-13, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11393343

RESUMO

We measured leptin concentrations in patients with acute myocardial infarction (AMI, n = 21) and in 15 age-matched controls, and compared leptin concentrations with levels of other myocardial enzymes and indicators of AMI. Blood was sampled immediately after hospital admission and at 1 h, 2 h, 3 h, 6 h and 9 h, then every 12 h until 5 days post-admission. Patients were stratified into three groups according to peak leptin concentrations: hypoleptinaemia (< 3 ng/ml); normoleptinaemia (> or = 3 - < 15 ng/ml) and hyperleptinaemia (> or = 15 ng/ml). Hypoleptinaemic AMI patients had significantly increased concentrations of plasma lactate dehydrogenase compared with normoleptinaemic patients. No significant differences in other serum markers were noted between hyperleptinaemic and normoleptinaemic AMI patients. A significant negative correlation was found between the peak concentrations of leptin and interleukin 6. Leptin may play a role in the regulation of the development of cardiac damage in patients with AMI.


Assuntos
Leptina/sangue , Infarto do Miocárdio/sangue , Idoso , Feminino , Humanos , L-Lactato Desidrogenase/sangue , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/enzimologia
5.
Pediatr Hematol Oncol ; 18(4): 267-72, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11400651

RESUMO

The authors report on a 14-year-old boy who developed T-cell acute lymphoblastic leukemia (FAB:L1) displaying 4 immunophenotypically distinct leukemic cell populations by 3-color immunofluorescence staining. Cytogenetic analysis at diagnosis showed 46,XY,add(4)(p16)[12]/46,XY[2]. A single rearrangement of the T-cell antigen receptor beta- and gamma-chain genes in these cells indicated monoclonality of the leukemic cells. These findings suggest that leukemic blast cells of monoclonal origin in this case were divided into 4 immunophenotypic populations, representing various stages of differentiation.


Assuntos
Leucemia-Linfoma de Células T do Adulto/patologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/patologia , Adolescente , Diferenciação Celular , Análise Citogenética , Rearranjo Gênico da Cadeia beta dos Receptores de Antígenos dos Linfócitos T , Rearranjo Gênico da Cadeia gama dos Receptores de Antígenos dos Linfócitos T , Humanos , Imunofenotipagem , Leucemia-Linfoma de Células T do Adulto/genética , Leucemia-Linfoma de Células T do Adulto/imunologia , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/genética , Leucemia-Linfoma Linfoblástico de Células Precursoras/imunologia
6.
Chemotherapy ; 47(4): 297-303, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11399867

RESUMO

BACKGROUND: The c-erbB-2 oncogene encodes a transmembrane tyrosine kinase receptor and its abnormal expression may be related to the prognosis of gastric cancer. Gastric cancer is relatively resistant to various drugs, including cisplatin. Cisplatin is widely used in cancer chemotherapy, but the mechanisms of drug resistance are not yet known. METHODS: We used the human gastric cancer cell lines MKN-7 and KATO-III, which express the c-erbB-2 oncogene, as a model for relative resistance to cisplatin. We investigated whether inhibition with antisense oligonucleotides against c-erbB-2 increased the sensitivity of MKN-7 and KATO-III cells to cisplatin. RESULTS: Antisense oligonucleotides for c-erbB-2 inhibited the expression of c-erbB-2 mRNA and protein and increased sensitivity to cisplatin, but not to other drugs, in MKN-7 and KATO-III cells. Cell growth was also inhibited by c-erbB-2 antisense oligonucleotides but not sense oligonucleotides. CONCLUSION: These findings indicate that c-erbB-2 expression in gastric cancer is one of the factors related to cisplatin sensitivity, and that anti-c-erbB-2 antisense oligonucleotides induced increased sensitivity to cisplatin.


Assuntos
Antineoplásicos/farmacologia , Cisplatino/farmacologia , Genes erbB-2/efeitos dos fármacos , Oligonucleotídeos Antissenso/farmacologia , Neoplasias Gástricas/tratamento farmacológico , Genes erbB-2/fisiologia , Humanos , Proteínas de Neoplasias/metabolismo , Proteínas Oncogênicas v-erbB/metabolismo , Neoplasias Gástricas/genética , Células Tumorais Cultivadas
7.
Oncol Rep ; 8(4): 807-10, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11410788

RESUMO

Human colon cancer SW480DDP and SW620DDP cells resistant to cisplatin exhibited stronger c-myb gene expression than the parent SW480 and SW620 cells. However, cell growth rates in the cisplatin-resistant cell lines remained similar to those of the parent cells. Antisense oligonucleotides to c-myb inhibited c-myb expression and induced increased sensitivity to cisplatin in SW480DDP and SW620DDP cells, but this did not occur with the control sense oligonucleotides. In contrast, the parent cell lines were not affected by antisense oligonucleotides to c-myb. These results indicate that the c-myb gene in human colon cancer is one of the factors related to cisplatin resistance, and support the need to develop anti-cancer therapeutics based on oncogene-targeted antisense oligonucleotide technology.


Assuntos
Adenocarcinoma/tratamento farmacológico , Antineoplásicos/uso terapêutico , Cisplatino/uso terapêutico , Neoplasias do Colo/tratamento farmacológico , Oligonucleotídeos Antissenso/uso terapêutico , Proteínas Proto-Oncogênicas c-myb/genética , Adenocarcinoma/genética , Divisão Celular/efeitos dos fármacos , Neoplasias do Colo/genética , Resistencia a Medicamentos Antineoplásicos , Sinergismo Farmacológico , Genes myb , Humanos , Reação em Cadeia da Polimerase , Proteínas Proto-Oncogênicas c-myb/biossíntese , RNA Mensageiro/análise , RNA Mensageiro/genética , RNA Neoplásico/análise , RNA Neoplásico/genética , Células Tumorais Cultivadas
8.
Br J Haematol ; 113(1): 52-7, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11328281

RESUMO

Aplastic anaemia is characterized by reduced haematopoiesis resulting in pancytopenia. It has been speculated that there is an injury in haematopoietic stem cells in the bone marrow; however, the precise nature of the injury has not been elucidated. In this study, the levels of expression of mRNAs for three transcription factors, GATA-2, SCL and AML1, which function in the early stages of haematopoiesis, were examined by quantitative polymerase chain reaction in patients with aplastic anaemia, idiopathic thrombocytopenic purpura (ITP) and normal subjects. Among these factors, expression of GATA-2 mRNA in purified CD34-positive cells was markedly decreased in aplastic anaemia compared with that in ITP and in normal subjects. The expression levels of SCL and AML1 mRNA in CD34-positive cells in aplastic anaemia were not different from those in normal subjects. When the expression of GATA-2 protein in CD34-positive cells was examined by immunocytochemical analysis, the percentage of GATA-2-positive cells in aplastic anaemia was lower than that in normal subjects. These findings strongly suggest that there is an aberrant expression of transcription factors in stem cells in aplastic anaemia, which may be responsible for the development of the disease.


Assuntos
Anemia Aplástica/metabolismo , Proteínas de Ligação a DNA/genética , Células-Tronco Hematopoéticas/metabolismo , Proteínas Proto-Oncogênicas , Fatores de Transcrição/genética , Antígenos CD34 , Fatores de Transcrição Hélice-Alça-Hélice Básicos , Estudos de Casos e Controles , Subunidade alfa 2 de Fator de Ligação ao Core , Citometria de Fluxo , Fator de Transcrição GATA2 , Expressão Gênica , Células-Tronco Hematopoéticas/imunologia , Humanos , Imuno-Histoquímica , Reação em Cadeia da Polimerase/métodos , Proteína 1 de Leucemia Linfocítica Aguda de Células T
9.
Anticancer Drugs ; 12(4): 325-9, 2001 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11335788

RESUMO

c-raf-1, a cytoplasmic serine/threonine protein kinase, plays an important role in mitogen- and damage-responsive cellular signal transduction pathways. Expression of c-raf-1 modifies cell growth, proliferation and survival. Although expression of c-raf-1 has been studied in several tumors, the role of c-raf-1 in leukemia is so far unclear. We examined the expression of c-raf-1 in the human leukemia cell lines U937 and K562, and in a cytosine arabinoside (Ara-C)-resistant cell line (K562AC) derived from K562. Expression of c-raf-1 was increased in U937 and in Ara-C-resistant K562AC cells compared with the parental cells. We then investigated whether inhibition of c-raf-1 expression by antisense oligonucleotides increases the sensitivity to Ara-C in U937 and K562AC cells. Antisense oligonucleotides for c-raf-1 inhibited expression of c-raf-1 mRNA, but did not affect cell growth and increased sensitivity to Ara-C but not to other drugs such as adriamycin, VP-16 or vincristine. These results suggest that c-raf-1 is one of the factors involved in Ara-C resistance in leukemia and lend weight to the case for development of anti-cancer therapeutics involving oncogene-targeted antisense oligonucleotides.


Assuntos
Citarabina/farmacologia , Células K562/efeitos dos fármacos , Leucemia/tratamento farmacológico , Oligonucleotídeos Antissenso/administração & dosagem , Proteínas Proto-Oncogênicas c-raf/efeitos dos fármacos , Antimetabólitos Antineoplásicos/farmacologia , Northern Blotting , Divisão Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Resistencia a Medicamentos Antineoplásicos/genética , Sinergismo Farmacológico , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Células K562/citologia , Leucemia/genética , Leucemia/metabolismo , Oligonucleotídeos Antissenso/genética , Proteínas Proto-Oncogênicas c-raf/biossíntese , Proteínas Proto-Oncogênicas c-raf/genética , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia , Células U937/citologia , Células U937/efeitos dos fármacos
10.
J Endocrinol ; 169(2): 417-24, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11312158

RESUMO

Zinc at concentrations of 150, microM or higher induced necrosis as well as apoptosis in thyroid cancer cell lines. Necrosis was induced by zinc in a dose-dependent manner, whereas apoptosis did not increase at higher concentrations of zinc. The expression of the antiapoptotic protein phosphorylated Bad was markedly increased, whereas the expression of the proapoptotic proteins Bax and Bad decreased following Zn(2+) exposure. Zn(2+) induced rapid degradation of IkappaB, and an increase in the binding of nuclear transcription factor-kappaB (NF-kappaB). These observations indicate that antiapoptotic pathways were activated in thyroid cancer cells following exposure to Zn(2+). This may be a self-defence mechanism against apoptosis and may underlie the general resistance of thyroid cancer cells to apoptotic stimuli. Zinc may be a potential cytotoxic agent for the treatment of thyroid cancer.


Assuntos
Apoptose/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-bcl-2 , Neoplasias da Glândula Tireoide/tratamento farmacológico , Neoplasias da Glândula Tireoide/patologia , Zinco/uso terapêutico , Animais , Biomarcadores/análise , Western Blotting , Proteínas de Transporte/metabolismo , Linhagem Celular , Corantes , Relação Dose-Resposta a Droga , NF-kappa B/metabolismo , Necrose , Proteínas Proto-Oncogênicas/metabolismo , Ratos , Neoplasias da Glândula Tireoide/metabolismo , Proteína X Associada a bcl-2 , Proteína de Morte Celular Associada a bcl
11.
Cardiology ; 93(3): 191-6, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10965091

RESUMO

Interleukin-6 (IL-6), a proinflammatory cytokine, plays a key role in the pathogenesis of coronary artery disease (CAD). We investigated circulating IL-6 and its receptors in patients with CAD. We evaluated 39 Japanese patients with CAD (30 males and 9 females aged 36-79 years), measuring their plasma levels of IL-6 and IL-6 receptors alpha and beta (IL-6R alpha, IL-6R beta). Circulating levels of IL-6, IL-6R alpha and IL-6R beta were measured by an enzyme-linked immunosorbent assay. Blood was sampled immediately after admission and again after 1, 2, 3, 6 and 9 h, then every 12 h for 5 days. Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) were measured on day 3 after symptom onset. Plasma levels of IL-6 and IL-6Rs were significantly increased in 28 patients with acute myocardial infarction (AMI) compared with 15 normal controls. However, neither IL-6 nor IL-6Rs showed an increase in 6 patients with angina pectoris. We observed two peaks for circulating IL-6 in AMI, the first of which showed a significant correlation with ANP as well as BNP. These results may help to explain why the amount of IL-6 produced is closely related to the severity of myocardial dysfunction in patients with CAD.


Assuntos
Interleucina-6/sangue , Infarto do Miocárdio/sangue , Receptores de Interleucina-6/sangue , Adulto , Idoso , Fator Natriurético Atrial/sangue , Biomarcadores/sangue , Cateterismo Cardíaco , Angiografia Coronária , Progressão da Doença , Ecocardiografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/diagnóstico , Infarto do Miocárdio/fisiopatologia , Peptídeo Natriurético Encefálico/sangue , Prognóstico , Radioimunoensaio , Índice de Gravidade de Doença , Volume Sistólico
12.
Rapid Commun Mass Spectrom ; 14(11): 947-9, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10844730

RESUMO

A new technique for accurate mass determination by using multiple sprayers nano-electrospray ionization mass spectrometry (nano-ESI-MS) on a magnetic sector instrument is described. Metal coated glass capillaries were used as nano-ESI sprayers. One of the sprayers was used for the reference compound solution, and others were used for the introduction of sample solutions. The spectra of the different compounds were obtained by shifting each sprayer's position relative to the sampling orifice. The accurate masses of several standard compounds were obtained with good accuracy, without problems arising from differences in ionization efficiency between the sample compounds and reference compound.


Assuntos
Encefalina Leucina/análise , Eritromicina/análise , Espectrometria de Massas/métodos , Polietilenoglicóis/análise , Reserpina/análise , Espectrometria de Massas/instrumentação , Peso Molecular , Reprodutibilidade dos Testes
13.
Rinsho Byori ; 48(2): 162-6, 2000 Feb.
Artigo em Japonês | MEDLINE | ID: mdl-10804820

RESUMO

The failure of chemotherapy to eradicate tumor cells is often due to the development of drug resistance. MDR(multidrug resistance) whose one form of resistance results from a decreased intracellular accumulation of the drugs, most often mediated by the overexpression of P-glycoprotein. MRP also related to pump function of cell membrane in acute leukemia. We have developed the new quantitative assay based on real-time PCR to measure expression of drug-resistance related genes such as MDR-1 and MRP in clinical samples. These results indicates that real-time PCR system is a reliable method to quantitatively determine drug resistant genes expression, it may be to predict responsiveness to chemotherapy by using this technique.


Assuntos
Resistência a Múltiplos Medicamentos/genética , Neoplasias/genética , Expressão Gênica , Humanos , Neoplasias/tratamento farmacológico , Reação em Cadeia da Polimerase/métodos
14.
Eur J Haematol ; 64(4): 252-8, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10776697

RESUMO

We evaluated the usefulness of a recently developed real-time reverse transcriptase polymerase chain reaction (RT-PCR) system to detect minimal residual diseases (MRD) in patients with acute myelogenous leukaemia (AML) with chromosomal translocation t(8:21). The method was simple, rapid and reproducible for the quantity of chimeric AML1-ETO (MTG8) transcripts. The ratio of the absolute copy number of a target gene (AML1-ETO) to a control gene (glyceraldehyde-3-phosphate dehydrogenase, GAPDH) was calculated by using a fluorescence curve prepared from amplicons of serially diluted standard RNA. The relative points of MRD in bone marrow (BM) of 8 patients in the acute phase of the disease was from 0.85 to 3.0, whereas those of MRD in complete remission (CR) decreased to below 6.4 x 10(-3). This method was also applied to evaluate chimeric transcripts in peripheral blood (PB) samples. The values in patients with t(8;21) AML were from 0.97 to 2.0 in the acute phase, whereas those in CR showed less than 2.2 x 10(-4). There was 10(-5)-fold difference in AML1-ETO mRNA expression between PB samples in the acute phase and those in CR. The results suggest that we may easily monitor MRD in patients with t(8;21) AML through quantitative analysis of AML1-ETO transcripts in blood samples.


Assuntos
Cromossomos Humanos Par 21 , Cromossomos Humanos Par 8 , Leucemia Mieloide Aguda/diagnóstico , Leucemia Mieloide Aguda/genética , Proteínas de Fusão Oncogênica/genética , Reação em Cadeia da Polimerase/métodos , Fatores de Transcrição/genética , Translocação Genética , Subunidade alfa 2 de Fator de Ligação ao Core , Humanos , Leucemia Mieloide Aguda/patologia , Neoplasia Residual/diagnóstico , Neoplasia Residual/genética , Sondas de Oligonucleotídeos , Proteínas de Fusão Oncogênica/análise , Proteína 1 Parceira de Translocação de RUNX1 , Fatores de Transcrição/análise , Células Tumorais Cultivadas
15.
Rinsho Byori ; 48(1): 54-9, 2000 Jan.
Artigo em Japonês | MEDLINE | ID: mdl-10756676

RESUMO

We constructed the standard RNA synthesized for the chimeric AML1-MTG8 transcripts and the house-keeping gene, glyceraldehyde-3-phosphate dehydrogenase(GAPDH) transcripts in real-time quantitative RT-PCR system. AML-MTG8 transcripts was detectable in 10 fg of synthetic RNA(3.5 x 10(3) copies). Linearity was from 3.5 x 10(3) to 3.5 x 10(9) copies. Threshold cycle(CT) is defined as the fractional cycle number at which the reporter fluorescence generated by cleavage of the probe passes a fixed threshold above baseline. The standard curve, where the known amounts of RNAs were used, showed a good correlation between the copies of AML1-MTG8 RNA and CT(r = -0.995). The within-run and day-to-day coefficients of variation(CV) in AML1-MTG8 RNA by this system were 9.5-24.7%(n = 10) and 21.7-42.2% (n = 8), respectively. GAPDH transcripts was detectable in 10 fg of synthetic RNA(6.1 x 10(4) copies). Linearity was from 6.1 x 10(4) to 6.1 x 10(8) copies. The standard curve, where the known amounts of RNAs were used, showed a good correlation between the copies of GAPDH RNA and CT(r = -0.993). The within-run and day-to-day CV in GAPDH RNA by this system were 9.3-14.6%(n = 10) and 14.7-15.8% (n = 10), respectively. Thus, we suggested that synthesized RNA as a standard RNA may be useful in quantitative RT-PCR for clinical application.


Assuntos
Reação em Cadeia da Polimerase , RNA/normas , Subunidade alfa 2 de Fator de Ligação ao Core , Gliceraldeído-3-Fosfato Desidrogenases/genética , Humanos , Proteínas de Fusão Oncogênica/genética , Proteína 1 Parceira de Translocação de RUNX1 , Fatores de Transcrição/genética
16.
Leuk Res ; 24(6): 535-41, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10781689

RESUMO

Cells of the human leukemia line K562 were continuously exposed to cytosine arabinoside (Ara-C) at increasing concentrations for 3 months. The resulting cell line, termed K562/AC, showed 48-fold resistance to Ara-C, compared with the parental K562 cells. The sensitivities of K562/AC to adriamycin (ADR), vincristine (VCR) and etoposide (VP16) were similar to those of parental K562. Gene analysis revealed that this cell line lacked expression of the deoxycytidine kinase (dCK) gene, which was evident in Ara-C-sensitive cells. As in K562 cells, multidrug resistance (MDR-1) and multidrug resistance protein (MRP) genes were not expressed in K562/AC. We also established an in vitro model of Ara-C resistance using phosphorothioate antisense oligonucleotides to dCK (dCK-AS). Treatment of K562 with dCK-AS caused decreased dCK expression and 6- to 10-fold increases in resistance to Ara-C, compared with that in cells treated with sense oligonucleotides to dCK (dCK-S) or in non-transfected cells. The cells described here may contribute to the study of a novel mechanism associated with Ara-C resistance, in which reduced dCK activity may play an important role.


Assuntos
Antimetabólitos Antineoplásicos/uso terapêutico , Citarabina/uso terapêutico , Ensaios de Seleção de Medicamentos Antitumorais , Leucemia/tratamento farmacológico , Resistencia a Medicamentos Antineoplásicos , Regulação Neoplásica da Expressão Gênica , Humanos , Leucemia/genética , Oligodesoxirribonucleotídeos Antissenso/farmacologia , Reação em Cadeia da Polimerase , Células Tumorais Cultivadas
17.
Plant Cell Physiol ; 41(1): 124-8, 2000 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-10750718

RESUMO

We present a novel method for direct introduction of chemicals into a sieve tube of intact rice plants-namely, the method of micro-introduction using stylet of insect (the MUSI method). Fluorescent dyes were successfully introduced into a sieve tube through a severed stylet of planthopper and the distribution of the dyes was observed.


Assuntos
Corantes Fluorescentes/farmacocinética , Oryza/metabolismo , Folhas de Planta/metabolismo , Animais , Fluoresceína-5-Isotiocianato/administração & dosagem , Fluoresceína-5-Isotiocianato/farmacocinética , Corantes Fluorescentes/administração & dosagem , Insetos , Microinjeções/métodos , Microscopia de Fluorescência , Rodaminas/administração & dosagem , Rodaminas/farmacocinética
18.
Rinsho Byori ; 48(10): 887-91, 2000 Oct.
Artigo em Japonês | MEDLINE | ID: mdl-11215098

RESUMO

Advancement molecular diagnostics in hematological malignancy has provided us with a broad menu of new assays and techniques. By integrating the data gleaned from these techniques we can formulate a more rational broad-based diagnosis. Hematological malignancies have traditionally been classified by morphological criteria. However, molecular advances have provided new insights in the genetic backbone of chimeric genes. These malignancies have shown chromosome abnormalities of translocation with chimeric genes, and revealed the rearrangement of chimeric genes by PCR analysis and quantitative PCR system. This review summarized the recent technology for detecting chimeric genes along with concepts of laboratory performance.


Assuntos
Técnicas de Laboratório Clínico , Neoplasias Hematológicas/diagnóstico , Laboratórios Hospitalares , Adulto , Aberrações Cromossômicas , Transtornos Cromossômicos , Feminino , Rearranjo Gênico , Neoplasias Hematológicas/genética , Humanos , Hibridização in Situ Fluorescente , Análise de Sequência com Séries de Oligonucleotídeos , Reação em Cadeia da Polimerase , Proteínas Recombinantes de Fusão/genética
19.
J Biochem ; 126(5): 859-65, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10544278

RESUMO

Based on the nuclear magnetic resonance assignments of a dimeric protein, Streptomyces subtilisin inhibitor (SSI), microscopic details of secondary structures in solution have been elucidated. The chemical shift index of C(alpha) signals, together with information on the hydrogen exchange rates of the backbone amide protons, were used to identify secondary structures. The locations of these secondary structures were found to be different in some critical points from those determined earlier by X-ray crystallography of the crystal. Notably, the beta3 strand is completely missing and the alpha2 helix is extended toward the C-terminus. Furthermore, hydrogen exchange experiments of individual peptide NH protons under strongly folding conditions revealed mechanisms of global and local structural fluctuation within the dimeric structure. It has been suggested that the global fluctuation of the monomeric unit occurs without affecting the accompanying monomer, in contrast to the equilibrium thermal unfolding, which is cooperative. Higher protection against hydrogen exchange for residues in part of the beta4 strand implies that this region might serve as a folding core.


Assuntos
Proteínas de Bactérias/química , Inibidores de Serina Proteinase/química , Streptomyces/química , Subtilisinas/antagonistas & inibidores , Sequência de Aminoácidos , Dimerização , Espectroscopia de Ressonância Magnética , Modelos Moleculares , Estrutura Quaternária de Proteína , Estrutura Secundária de Proteína , Estrutura Terciária de Proteína , Termodinâmica
20.
J Am Soc Mass Spectrom ; 6(12): 1137-42, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24214064

RESUMO

The gas-phase stabilities of cluster ions SF m (+) (SF6) n with m = 0-5 were determined by using a high pressure mass spectrometer. The bond energies of SF m (+) (SF6)1 were found to be less than 10 kcal/mol and to decrease with m = 0 → 5. There appear to be rather large gaps in the bond energies between n = 1 and 2 for the clusters SF m (+) (SF6) n with m = 0-4. The structures of SF 5 (+) , SF(+) (SF6)1 SF 3 (+) (SF6)1 and SF 5 (+) (SF6)1, were investigated by ab initio molecular orbital calculations. For SF 5 (+) , the D 3h geometry is found to be most stable and C 4v is a transition state of the Berry pseudorotation. For the ion-molecule complexes, the "on-top hat" models were found to be the most stable structures.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...